Sheps, S.G., et al: Effect of Methyldopa on Metabolism of Catecholamines and Tryptophan in Two Cases of Metastatic Pheochromocytoma, unpublished data.
Karmen, A.: Note on Spectrophotometric Assay of Glutamic-Oxaloacetic Transaminase in Human Blood Serum , J Clin Invest 34:131 (
(Jan 1)
) 1955;.
Cannon, P.J., et al: Effect of α-Methyl DOPA in Severe and Malignant Hypertension , JAMA 179:673 (
(March 3)
) 1962;.
Leonard, J.W.; Gifford, R.W., Jr.; and Humphrey, D.C.: Febrile Reactions to L,-α-Methyldopa: Report of Three Cases , Cleveland Clin Quart 29:144 (
(July)
) 1962;.
Gillespie, L., Jr.: Clinical Pharmacology of Newer Antihypertensive Agents Monoamine Oxide and Decarboxylase Inhibitors, Bretylium Tosylate, and Guanethidine , Ann NY Acad Sci 88:1011 (
(Oct 11)
) 1960;.
Irvine, R.O.H.; O'Brien, K.P.; and North, J.D.K.: α-Methyl-Dopa in Treatment of Hypertension , Lancet 1:300 (
(Feb 10)
) 1962;.
Stone, CA., et al: Effect of α-Methyl-3, 4-dihydroxyphenylalanine (Methyldopa) Reserpine and Related Agents on Some Vascular Responses in Dog , J Pharmacol Exp Ther 136:80 (
(April)
) 1962;.
Dollery, C.T., and Harington, M.: Methyldopa in Hypertension: Clinical and Pharmacological Studies , Lancet 1:759 (
(April 14)
) 1962;.
Bayliss, R.I.S., and Harvey-Smith, E.A.: Methyldopa in Treatment of Hypertension , Lancet 1:763 (
(April 14)
) 1962;.
Hallwright, G.P.: Agranulocytosis Caused by Methyl Dopa (Aldomet) , New Zeal Med J 60:567 (
(Dec)
) 1961;.
Kirkendall, W.M., and Wilson, W.R.: Pharmacodynamics and Clinical Use of Guanethidine, Bretylium, and Methyldopa , Amer J Cardiol 9:107 (
(Jan)
) 1962;.
Oates, J.A., et al: Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3, 4-dihydroxy-DL-phenylalanine, Abstract , Science 131:1890 (
(June 24)
) 1960;.
Stone, C., et al: " Pharmacology of Decarboxylase Inhibitors ," in Brest, A., and Moyer, J.: Hypertension: Recent Advances , Philadelphia: Lea & Febiger, 1961;, pp 417-423.
Hess, S.M., et al: Effects of α-Methyl-dopa and α-Methyl-metatyrosine on Metabolism of Norepinephrine and Serotonin in Vivo , J Pharmacol Exp Ther 134:129 (
(July)
) 1961;.
Goldberg, L.I.; DaCosta, F.M.; and Ozaki, M.: Actions of Decarboxylase Inhibitor, α-Methyl-3, 4-dihydroxyphenylalanine, in Dog , Nature 188:502 (
(Nov 5)
) 1960;.
Onesti, G., et al: Pharmacodynamic Effects and Clinical Use of Alpha Methyldopa in Treatment of Essential Hypertension , Amer J Cardiol 9:863 (
(June)
) 1962;.
Wilson, W.R.; Fisher, F.D.; and Kirkendall, W.M.: Acute Hemodynamic Effects of α-Methyl-dopa in Man, Abstract , J Clin Invest 40:1089 (
(June)
) 1961;.
Sannerstedt, R.; Varnauskas, E.; and Werko, L.: Hemodynamic Effects of Methyldopa (Aldomet) at Rest and During Exercise in Patients with Arterial Hypertension , Acta Med Scand 171:75, 1962;.
Faulk, W.T., and Fleisher, G.A.: Effects of Opiates on Activity of Serum Transaminase , Proc Mayo Clin 32:405 (
(Aug 7)
) 1957;.